Trillium Therapeutics (TRIL) News Today → This unknown company solves the biggest issue with AI (From Manward Press) (Ad) Free TRIL Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 1, 2024 | msn.comTTI, REPX among major energy losers; EU major gainerApril 11, 2024 | seekingalpha.comSYRE Spyre Therapeutics, Inc.February 22, 2024 | benzinga.comViking Therapeutics Stock (NASDAQ:VKTX), Analyst Ratings, Price Targets, PredictionsFebruary 21, 2024 | health.usnews.comBlue Cross & Blue Shield of Rhode Island Insurance Company Medicare Advantage Plans with Part DApril 7, 2023 | marketwatch.com2023-2030 Bromodomain Containing Protein 2 Market Size Detailed Report with Sales and Revenue Analysis | Research by Absolute ReportsMarch 23, 2023 | finance.yahoo.comMonte Rosa Therapeutics Appoints Dr. Jan Skvarka to Board of DirectorsMarch 13, 2023 | finance.yahoo.comRatio Therapeutics Appoints Dr. Noel Monks as Head of BiologyMarch 13, 2023 | reuters.comFactbox: Pfizer snaps up Seagen for $43 bln as drugmaker extends buying spreeFebruary 24, 2023 | benzinga.comAllogene Therapeutics Stock (NASDAQ:ALLO), Quotes and News SummaryFebruary 23, 2023 | finance.yahoo.comTvardi Therapeutics Announces First Patients Dosed in Phase 2 Trial of TTI-101 in Metastatic Breast CancerFebruary 6, 2023 | markets.businessinsider.comViridian Therapeutics Names Scott Myers CEO, Succeeding Jonathan ViolinOctober 26, 2022 | finance.yahoo.comAlex Therapeutics presents results from digital therapeutic pilot study showing nearly 50% reduction in anxietyAugust 5, 2022 | finance.yahoo.comPfizer in advanced talks to buy Global Blood Therapeutics for $5 billion - WSJJuly 29, 2022 | ca.finance.yahoo.comLeukemia Therapeutics Global Market Report 2022July 18, 2022 | thestreet.comTrillium Therapeutics Inc. NewsJune 10, 2022 | finance.yahoo.comRatio Therapeutics Launches to Discover and Drive Early Clinical Development of Best-in-Class Targeted Radiopharmaceuticals for Treatment of CancersMay 10, 2022 | chron.comPfizer Pays $11.6 Billion for Drug-Maker in Its Biggest Deal Since 2016May 10, 2022 | finanznachrichten.deBloom Burton & Co. Inc.: Three Finalists Announced for the 2022 Bloom Burton AwardMay 10, 2022 | stockhouse.comThree Finalists Announced for the 2022 Bloom Burton AwardMay 10, 2022 | yahoo.comPfizer to buy migraine drugmaker Biohaven in $11.6-billion dealJanuary 26, 2022 | finance.yahoo.comGenScript ProBio Initiates a CDMO Contract For Next-Generation CD47 Antibody with InnoBation BioDecember 16, 2021 | au.finance.yahoo.comCD47 Targeting Global Therapeutics Market 2021-2035, by Target Disease Indication, Type of Molecule Key Players and Key Geographical RegionsOctober 28, 2021 | finance.yahoo.comTrillium Therapeutics Receives Final Court Order Approving ArrangementOctober 26, 2021 | theglobeandmail.comShareholders of cancer-drug developer Trillium Therapeutics approve takeover by Pfizer Inc.October 26, 2021 | finance.yahoo.comTrillium Securityholders Approve Acquisition by PfizerOctober 13, 2021 | law360.comPfizer Gives Gov't More Time To Study $2.3B Trillium DealOctober 5, 2021 | finance.yahoo.comIs Trillium Therapeutics Inc. (TSE:TRIL) Popular Amongst Institutions?September 14, 2021 | markets.businessinsider.comHere's the Biotech Pfizer Should Consider Acquiring NextAugust 26, 2021 | finance.yahoo.comINVESTIGATION: Halper Sadeh LLP Investigates LMRK, HFC, NLOK, TRIL, LDL; Shareholders are Encouraged to Contact the FirmAugust 24, 2021 | finance.yahoo.comSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Trillium Therapeutics Inc. (Nasdaq – TRIL)August 23, 2021 | businesswire.comTRILLIUM THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Trillium ...August 23, 2021 | marketbeat.comTrillium, Analog Devices rise: General Motors, Lennar fallStocks that traded heavily or had substantial price changes Monday: Trillium, Analog Devices rise; General Motors, Lennar fallAugust 23, 2021 | thestreet.comTop 5 Stock Gainers for Monday: Pfizer, Trillium, NextGen, VivosAugust 23, 2021 | markets.businessinsider.comMid-Morning Market Update: Markets Open Higher; Pfizer To Acquire Trillium TherapeuticsAugust 23, 2021 | finance.yahoo.comPfizer Beefs Up Blood Cancer Pipeline With Trillium Acquisition: See HighlightsAugust 23, 2021 | finance.yahoo.comWhy Trillium Therapeutics Stock Is Skyrocketing TodayAugust 23, 2021 | finance.yahoo.comPfizer to Acquire Cancer Drugmaker Trillium for $2.3 BillionAugust 23, 2021 | finance.yahoo.comPfizer Agrees to Buy Cancer Biotech Trillium Therapeutics at a 200% PremiumAugust 23, 2021 | finance.yahoo.comPfizer Nabs Cancer Deal For $2.26 Billion, Helping Trillium Stock SkyrocketAugust 23, 2021 | finance.yahoo.comTropical Storm Henri’s mayhem, Boeing invests in Virgin Orbit, Pfizer’s newest acquisitionAugust 23, 2021 | finance.yahoo.comTrillium Therapeutics Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Trillium Therapeutics Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – TRILAugust 23, 2021 | marketbeat.comPfizer to pay $2.26B for cancer treatment developer TrilliumPfizer is spending more than $2 billion in cash to buy another drugmaker focused on potential cancer treatmentsAugust 13, 2021 | chron.comTrillium: Q2 Earnings SnapshotAugust 11, 2021 | morningstar.comNorth American Morning Briefing: Investors Await -3-July 22, 2021 | finance.yahoo.comTSX falls 0.06% to 20,097.52 Get Trillium Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TRIL and its competitors with MarketBeat's FREE daily newsletter. Email Address This is the best new way to score with AI (Ad)If you thought that you missed your chance to score big on AI, I have great news. A rare second profit window is starting to open. Click now for the best way into the newest AI projects TRIL Media Mentions By Week TRIL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TRIL News Sentiment▼0.000.55▲Average Medical News Sentiment TRIL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TRIL Articles This Week▼00▲TRIL Articles Average Week Get Trillium Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TRIL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Tilray Brands News Cronos Group News Canopy Growth News Bausch Health Companies News dentalcorp News Sienna Senior Living News WELL Health Technologies News Neighbourly Pharmacy News Extendicare News Fennec Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:TRIL) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks News[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperPharma Giant Makes Deal with a "Drug Smuggler"Behind the MarketsHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trillium Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
